Oral Corticosteroid Use During Pregnancy and the Risk of Gestational Diabetes

Does oral corticosteroid use during pregnancy increase the risk of gestational diabetes?In this cohort study of 1 325 940 pregnancies resulting in live births, oral corticosteroid use between 1 and 27 weeks’ gestation was not associated with an increased risk of gestational diabetes compared with unexposed pregnancies.These results suggest that oral corticosteroid treatment during pregnancy does not elevate the risk of gestational diabetes and may be considered a reasonable therapeutic option for managing maternal conditions.

Corresponding Author: Ju-Young Shin, PhD, School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do 16419, South Korea (shin.jy@skku.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.